Search research articles
Contact Us
Filters
Showing results (211-220 of 471) with videos related to
Page
of 48
Sort By:
Journal of Medical Imaging and Radiation Oncology
|
June 1, 2013
Treatment response in the neck: p16+ versus p16- oropharyngeal cancer
Daisy Mak, Rodney J Hicks, Danny Rischin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 11, 2015
15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma
Keelan Byrne, Shankar Siva, Lori Chait, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 22, 2006
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer
Cuong P Duong, Rodney J Hicks, Leann Weih, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2024
Evaluating the Utility of <sup>18</sup>F-FDG PET/CT in Cancer of Unknown Primary
Tharani Sivakumaran, Anthony Cardin, Jason Callahan, et al.
EJNMMI Radiopharmacy and Chemistry
|
October 30, 2019
Automated preparation of clinical grade [<sup>68</sup>Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform
Mohammad B Haskali, Peter D Roselt, David Binns, et al.
Radiation Oncology (London, England)
|
December 17, 2014
Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes
Jason Callahan, Tomas Kron, Shankar Siva, et al.
Clinical Case Reports
|
April 12, 2018
Diagnostic challenges in a patient with an occult insulinoma:<sup>68 </sup>Ga-DOTA-exendin-4 PET/CT and <sup>68</sup>Ga-DOTATATE PET/CT
Elisa Bongetti, Melissa H Lee, David A Pattison, et al.
Internal Medicine Journal
|
September 20, 2018
Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists
Abby P Douglas, Karin A Thursky, Leon J Worth, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 13, 2017
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
Sue Ping Thang, Mei Sim Lung, Grace Kong, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2014
Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours
Raghava Kashyap, Michael S Hofman, Michael Michael, et al.
Page
of 48
Search research articles
Search
Showing results (211-220 of 471) with videos related to
Sort By:
Page
of 48
Journal of Medical Imaging and Radiation Oncology
|
June 1, 2013
Treatment response in the neck: p16+ versus p16- oropharyngeal cancer
Daisy Mak, Rodney J Hicks, Danny Rischin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 11, 2015
15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma
Keelan Byrne, Shankar Siva, Lori Chait, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 22, 2006
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer
Cuong P Duong, Rodney J Hicks, Leann Weih, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2024
Evaluating the Utility of <sup>18</sup>F-FDG PET/CT in Cancer of Unknown Primary
Tharani Sivakumaran, Anthony Cardin, Jason Callahan, et al.
EJNMMI Radiopharmacy and Chemistry
|
October 30, 2019
Automated preparation of clinical grade [<sup>68</sup>Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform
Mohammad B Haskali, Peter D Roselt, David Binns, et al.
Radiation Oncology (London, England)
|
December 17, 2014
Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes
Jason Callahan, Tomas Kron, Shankar Siva, et al.
Clinical Case Reports
|
April 12, 2018
Diagnostic challenges in a patient with an occult insulinoma:<sup>68 </sup>Ga-DOTA-exendin-4 PET/CT and <sup>68</sup>Ga-DOTATATE PET/CT
Elisa Bongetti, Melissa H Lee, David A Pattison, et al.
Internal Medicine Journal
|
September 20, 2018
Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists
Abby P Douglas, Karin A Thursky, Leon J Worth, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 13, 2017
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
Sue Ping Thang, Mei Sim Lung, Grace Kong, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 12, 2014
Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours
Raghava Kashyap, Michael S Hofman, Michael Michael, et al.
Page
of 48